Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Novavax, Inc. (NVAX)

Biohaven Ltd. and Novavax, Inc. are both Biotechnology companies. Biohaven Ltd. and Novavax, Inc. are of similar size ($1.8B and $1.8B). Biohaven Ltd. grew revenue faster over the last twelve months: 425.2% against −61.6%. Biohaven Ltd. has the higher net margin (0.00% vs −59.9%) and the lower return on invested capital (−9,245.4% vs 0.00%). Across the 16 metrics below, Novavax, Inc. leads on 9 and Biohaven Ltd. on 7.

Valuation

Metric BHVN NVAX Biotechnology median
P/E n/m n/m 8.58
P/S 2.25 3.98 10.29
P/B 182.90 n/m 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA n/m n/m 0.67
EV/Sales 2.24 2.95 9.89
Earnings yield (31.27%) (15.20%) (31.56%)
Free cash flow yield (23.79%) (2.68%) (23.42%)

Profitability

Metric BHVN NVAX Biotechnology median
Gross margin 0.00% 78.60% 65.77%
Operating margin 0.00% (56.58%) 0.00%
Net margin 0.00% (59.87%) 0.00%
Free cash flow margin 0.00% (10.20%) 0.00%
Return on equity (799.46%) 323.66% (54.09%)
Return on assets (127.41%) (21.62%) (47.78%)
Return on invested capital (9,245.36%) 0.00% 0.00%

Growth

Metric BHVN NVAX Biotechnology median
Revenue growth (TTM) 425.20% (61.64%) 5.83%
EPS growth (last fiscal year) 26.08% 309.76% 29.36%
Revenue growth, 5-year CAGR — 18.76% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN NVAX Biotechnology median
Debt to equity 21.23 (1.54) 0.00
Current ratio 4.73 2.33 4.80
Net debt to EBITDA 0.11 (1.04) 0.97

Dividend

Metric BHVN NVAX Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric BHVN NVAX Biotechnology median
Market cap 1.77b 1.82b 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack